5th gen glp 1 agonist Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society Frontiers | Unlocking the potential

10.1007/s00125-001-0719-z 4 AlhadeffA

One benefit of GLP-1 receptor agonists is that they do not cause hypoglycemia when combined with metformin or thiazolidinediones, but the dose of concomitant sulphonylurea or insulin may have to be decreased to reduce the risk of hypoglycemic episodes

Cardiovascular and renal outcomes with Efpeglenatide in type 2 diabetes

These guidelines are general and may not be suitable for every patient

513,522 In a mouse model induced with NASH-related HCC, treatment with liraglutide (a type of GLP-1RA) was shown to prevent the progression of hepatocellular carcinoma

Conclusion The findings of this systematic review and meta-analysis suggest that treatment with GLP-1 RAs may be associated with improvements across various intervals, including in papilledema and Visual Disturbances, which appear to be maintained for up to 24 months